HiT Barcelona

There are 14.2 million optical colonoscopies performed every year at an average cost of $2,000 each (a 28 billion/year potential market only in the US). Still, 150,000 people develop colon cancer and 60,000 die every year. Colon cancer is a largely curable disease when detected early. Unfortunately, because of its invasive nature, only 30% of people at risk (men and women over 50) undergo colon cancer tests.

Echopixel CTM enables doctors and radiologists to noninvasively convert CT scans into 3D models of the colon, using a “navigate and detect” approach for analysis. It accurately detects cancerous and pre-cancerous polyps, enhances screening capacity, reduces physician time and is capable of saving millions of dollars in treatment and many lives with early detection.